San Diego biotech news from San Diego Union Tribune, PR Newswire, Businesswire and other sources, click on headlines to read the full story and see what’s trending.

Unlocking therapies for hard-to-treat lung cancers
LA JOLLA?Around 85 percent of lung cancers are classified as non-small-cell lung cancers, or NSCLCs. Some patients with these cancers can be treated with targeted genetic therapies, and some benefit from immunotherapies?but the vast majority of NSCLC p… […]